Idenix Pharmaceuticals (IDIX)

[DewDiligence]

>hopefully this was known and factored into share price already…guess we'll find out tomorrow<

Nothing of consequence is happening in AH trading, FWIW.

The recent falloff from the mid 10s seemed overdone based on the public disclosures during the past few weeks. But the executive turnover raises new questions about what the heck is going on with the NM283 program.

If not for the NVS affiliation and the trustworthiness it confers, I would probably be bailing on account of this latest development. As it is, I will hold.